Cargando…
Sofosbuvir protects Zika virus-infected mice from mortality, preventing short- and long-term sequelae
Zika virus (ZIKV) causes significant public health concerns because of its association with congenital malformations, neurological disorders in adults, and, more recently, death. Considering the necessity to mitigate ZIKV-associated diseases, antiviral interventions are an urgent necessity. Sofosbuv...
Autores principales: | Ferreira, André C., Zaverucha-do-Valle, Camila, Reis, Patrícia A., Barbosa-Lima, Giselle, Vieira, Yasmine Rangel, Mattos, Mayara, Silva, Priscila de Paiva, Sacramento, Carolina, de Castro Faria Neto, Hugo C., Campanati, Loraine, Tanuri, Amilcar, Brüning, Karin, Bozza, Fernando A., Bozza, Patrícia T., Souza, Thiago Moreno L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5573375/ https://www.ncbi.nlm.nih.gov/pubmed/28842610 http://dx.doi.org/10.1038/s41598-017-09797-8 |
Ejemplares similares
-
The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication
por: Sacramento, Carolina Q., et al.
Publicado: (2017) -
Corrigendum: The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication
por: Sacramento, Carolina Q., et al.
Publicado: (2017) -
Yellow fever virus is susceptible to sofosbuvir both in vitro and in vivo
por: de Freitas, Caroline S., et al.
Publicado: (2019) -
Zika Virus Infects, Activates, and Crosses Brain Microvascular Endothelial Cells, without Barrier Disruption
por: Papa, Michelle P., et al.
Publicado: (2017) -
Metabolic reprogramming and lipid droplets are involved in Zika virus replication in neural cells
por: Dias, Suelen Silva Gomes, et al.
Publicado: (2023)